Large-cap biotech Loading... : Investor Sentiment and Bull/Bear Views

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
14:01
Jan 16
JC Parets Founder and Chief Technician, Trend Labs The Compound News
Large biotech basket looks strong.
Biotech is at its highest level since 2021; while single-name biotech has tape-bomb risk, a basket of larger biotech names above $1 billion market cap reduces that risk and is attractive.
MED

About Large-cap biotech Investor Commentary

Across the available history and selected sources, Buzzberg tracks Large-cap biotech across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: JC Parets.